19
© 2008 ubio . All rights reserved. 1 HIV testing Methods and Procedures

AIDS/HIV Testing Methodology ()

Embed Size (px)

DESCRIPTION

HIV testing methodologies: an Introduction for more presentations and tutorials visit http://www.ubio.in

Citation preview

Page 1: AIDS/HIV Testing Methodology ()

© 2008 ubio. All rights reserved. 1

HIV testing

Methods and Procedures

Page 2: AIDS/HIV Testing Methodology ()

© 2008 ubio. All rights reserved. 2

diagnosis of infectionacute, recent, established or late stage disease

prognostic markersmonitoring of ARV therapies

immunological and virological markerstoxicities

diagnosis of opportunistic infectionsdrug resistance testing

Laboratory Tests

Page 3: AIDS/HIV Testing Methodology ()

© 2008 ubio. All rights reserved. 3

Typical Primary HIV-1 Infection

symptoms

HIV-1 p24 antigen

0 1 2 3 4 5 6 / 2 4 6 8 10weeks years

HIV antibodies

Time following infection

HIV viral load

HIV proviral DNA

symptoms

‘window’period

1° infection

Page 4: AIDS/HIV Testing Methodology ()

© 2008 ubio. All rights reserved. 4

Types of HIV Assays

DIAGNOSIS

Virus Detection & Quantification

Antibody

Antigen

Detection

RNAmodified Ag

Viral Culture, phenotyping

CD4+

ARV Resistance – genotypingARV Sensitivity

EIASimple, rapid tests Immunoblots

Incident assays

MANAGEMENT

DNA(RNA)

Page 5: AIDS/HIV Testing Methodology ()

© 2008 ubio. All rights reserved. 5

HIV Test Spectrum

DNA PCRDNA PCRRNA PCRRNA PCR

p24 Agp24 Ag3rd gen ELISA1st gen ELISA

Detuned ELISA1wk 2wk 3wk 2mo 6mo 1yr 2yr 3yr +8yr

gp160gp120

p68p55p53

gp41-45

p40

p34

p24

p18

p12

gp160gp120

p68p55p53

gp41-45

p40

p34

p24

p18

p12

gp160gp120

p68p55p53

gp41-45

p40

p34

p24

p18

p12

early recent / established advanced

Page 6: AIDS/HIV Testing Methodology ()

© 2008 ubio. All rights reserved. 6

HIV p24 antigen– serologyIn isolation or Ab/Ag Combo test Diagnosis of primary infection viraemia

Virus culture/isolation Nucleic acid detection (NAT)

Clinical uses Proviral DNA vs. plasma RNA(viral load) resolution of

inconclusive serology/neonatalsubtypingdrug resistance monitoring

Direct Virus Detection

Page 7: AIDS/HIV Testing Methodology ()

© 2008 ubio. All rights reserved. 7

Principle of Immunoassays

SOLID PHASESOLID PHASESOLID PHASESOLID PHASE

ANTIGEN

SAMPLE ANTIBODY

ANTI-HUMAN IMMUNOGLOBULIN WITH DETECTOR

Page 8: AIDS/HIV Testing Methodology ()

© 2008 ubio. All rights reserved. 8

EIAs including rapid, simple assaysparticle agglutinationdot/blotWestern blotAntigen and Antibody/Antigen (Ab/Ag)Incidence assays

Direct Virus Detection

Available Assays

Page 9: AIDS/HIV Testing Methodology ()

© 2008 ubio. All rights reserved. 9

Dot/Blot Assays

Page 10: AIDS/HIV Testing Methodology ()

© 2008 ubio. All rights reserved. 10

Particle Agglutination Assays

Page 11: AIDS/HIV Testing Methodology ()

© 2008 ubio. All rights reserved. 11

technically more difficult visual interpretation lack standardisation

Performance

Interpretation ‘Gold Standard’ for confirmation

Western Blot

Page 12: AIDS/HIV Testing Methodology ()

© 2008 ubio. All rights reserved. 12

Difficulties in interpretation Limitations - ‘window period’ antibodies appear within 3-4 weeks

Direct detection for early detectionHIV p24 antigenDNA/RNA (NAT)

Combo test = earlier detection Primary infection + therapy = delayed antibody

response Incident populations – ‘at risk’

Antibody Testing: Limitations

Page 13: AIDS/HIV Testing Methodology ()

© 2008 ubio. All rights reserved. 13

Detection of Ag & Ab in a single test

utility in primary infection – pre-seroconversion ‘window period’

Useful for blood banks Automated platforms available

Ag/Ab Combo Tests

Ag & AbAg & AbAg & AbAg & Ab

Page 14: AIDS/HIV Testing Methodology ()

© 2008 ubio. All rights reserved. 14

Chance of false reactivityMight need confirmation testsReplacement by other assays

(especially in the USA)More expensive than Antibody assays

Ag/Ab Assays: Limitations

Page 15: AIDS/HIV Testing Methodology ()

© 2008 ubio. All rights reserved. 15

Detect HIV-1 & HIV-2 Cannot differentiate between HIV types Procedural control using anti human IgG Can test using whole blood, serum or

plasma Widely available No additional reagents required Storage at room temperature 15 minutes to get result

Simple Assays: HIV Determine

Page 16: AIDS/HIV Testing Methodology ()

© 2008 ubio. All rights reserved. 16

Detects HIV-1 and HIV-2Will differentiate between types 1 and 2Procedural control using anti-human IgGSerum/plasma only Need additional reagents (included in kit)Requires refrigerated storage ‘Immunoconcentration’ principle15 minutes to result

BioRad HIV-1/2 Multispot

Page 17: AIDS/HIV Testing Methodology ()

© 2008 ubio. All rights reserved. 17

Strategy I: Test all samples with one EIA Strategy II: Strategy I with all reactives retested in a more

specific test with different principle and/or antigen. Strategy III: Strategy II with reactives tested in a third test

differing from the first two tests. Transfusion Safety

Strategy I Surveillance

>10% Strategy I, < 10% Strategy II Diagnosis

>10% Strategy II, < 10% Strategy III

WHO Test Strategies

Page 18: AIDS/HIV Testing Methodology ()

© 2008 ubio. All rights reserved. 18

Use strategy for confirmationUse combination of affordable and simple assaysUse tests with different principlesUse different antigen preparations

Use two or three types of ELISAs or rapid tests diagnosis confirmed by second sample Use direct detection of virus (PCR) for final

confirmation Important: Always use a QC sample

WHO Test Guidelines

Page 19: AIDS/HIV Testing Methodology ()

© 2008 ubio. All rights reserved. 19

www.ubio.in